Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.
Hesperos has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in May 2024.
Hesperos's investors include National Institutes of Health, NCATS.
Hesperos is headquartered in Orlando, United States.
Hesperos, Inc, is a leader in efforts to characterize an individual’s biology with human-on-a-chip microfluidic systems.
Hesperos is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hesperos — Funding & Investors." VCBacked, May 7, 2024, https://www.vcbacked.co/company/hesperos. Accessed October 17, 2026.
VCBacked. (2024). Hesperos — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/hesperos
{{cite web |title=Hesperos — Funding & Investors |url=https://www.vcbacked.co/company/hesperos |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated